CASI Stock Analysis: Buy, Sell, or Hold?
CASI - CASI Pharmaceuticals, Inc. Ordinary Shares
$1.02
0.03 (3.02%)
▲
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Nov 21, 2025
0d
Get Alerted When CASI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CASI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: CASI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: CASI is currently trading at $1.02, which is considered slightly high relative to its 30-day fair value range of $0.82 to $1.04.
Technical Outlook: Technically, CASI is in a strong downtrend. The price is approaching resistance at $1.05. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.0% recently.
Market Sentiment: CASI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.00 (+304.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CASI is in a strong downtrend. The price is approaching resistance at $1.05. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.0% recently.
Market Sentiment: CASI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.00 (+304.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$0.82 -
$1.04
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
84.2%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.0%)
- BULLISH: Trading 304.0% below Wall St target ($4.00)
Fair Price Analysis
30-Day Fair Range
$0.82 -
$1.04
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.90
Resistance Level
$1.05
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.70
Wall Street Target
$4.00
(+304.0%)
Revenue Growth (YoY)
-60.5%
Profit Margin
-184.0%
Last updated: January 30, 2026 9:43 PM ET
Data refreshes hourly during market hours. Next update: 10:43 PM
Data refreshes hourly during market hours. Next update: 10:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CASI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$35 | 51 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$65 | 60 HOLD |
Advanced CASI Option Strategies
Professional options setups generated by AI based on today's CASI price and gamma walls.
